Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Sarcoma 1Rhabdomyosarcoma 1Ovarian Neoplasms 1Neuroectodermal Tumors, Primitive, Peripheral 1Malignant mesenchymal tumor 1

Interventions

Filgrastim 6Doxorubicin 6Radiotherapy 5Ifosfamide 5Vincristine 4Dactinomycin 4Cyclophosphamide 4sargramostim 3Trabectedin 2Radiotherapy, Conformal 2Irinotecan 2Granulocyte Colony-Stimulating Factor 2trioctyl phosphine oxide 1pegfilgrastim 1indolepropanol phosphate 1etoposide phosphate 1brostallicin 1Watchful Waiting 1Topotecan 1Radiation 1Observation 1Mass Spectrometry 1Imatinib Mesylate 1Granulocyte-Macrophage Colony-Stimulating Factor 1Glutamine 1Etoposide 1Chromatography, High Pressure Liquid 1Chemotherapy, Adjuvant 1BI 2536 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Malignant mesenchymal tumor × trioctyl phosphine oxide × Clear all
NCT00003958 2013-06-17

Combination Chemotherapy in Treating Patients With Previously Untreated Rhabdomyosarcoma

Children's Oncology Group

Phase 3 Completed
702 enrolled
Sarcoma

Malignant mesenchymal tumor, Rhabdomyosarcoma, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡